Celcuity/CELC
$16.89
0.71%-
1D1W1MYTD1YMAX
About Celcuity
Celcuity Inc. is a clinical-stage biotechnology company, which develops targeted therapies for the treatment of multiple solid tumor indications. Its lead therapeutic candidate is gedatolisib, a potent, small molecule reversible inhibitor, that selectively targets all Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic target of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2. Its initial clinical development programs for gedatolisib are focusing on the treatment of patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-), or HR+/HER2-, advanced or metastatic breast cancer and patients with metastatic castration resistant prostate cancer. Its VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast. Its CELsignia companion diagnostic platform is able to analyze live patient tumor cells to identify new groups of cancer patients.
Ticker
CELC
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology & Drugs
CEO
Brian Sullivan
Employees
55
Headquarters
Minneapolis, United States
Website
www.celcuity.com
Celcuity Metrics
BasicAdvanced
$511M
Market cap
-
P/E ratio
-$2.70
EPS
0.86
Beta
-
Dividend rate
Price and volume
Market cap
$511M
Beta
0.86067
52-week high
$22.19
52-week low
$8.39
Average daily volume
239K
Financial strength
Current ratio
13.433
Long term debt to equity
26.498
Total debt to equity
26.498
Management effectiveness
Return on assets (TTM)
-34.76%
Return on equity (TTM)
-46.63%
Return on investment (TTM)
-36.88%
Valuation
Price to book
3.06
Price to tangible book (TTM)
3.654
Growth
Earnings per share change (TTM)
-3.21%
What the Analysts think about Celcuity
Analyst Ratings
Majority rating from 6 analysts.
Price Targets
Average projection from 5 analysts.
High $40.00
Low $24.00
$16.89
Current price
$28.60
Average price target
Celcuity Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$0
NaN%
Net income
-$19M
2.17%
Profit margin
0%
NaN%
Celcuity Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.55
-$0.66
-$0.83
-$0.65
-
Expected
-$0.52
-$0.60
-$0.68
-$0.73
-$0.71
Surprise
6.28%
10.46%
21.61%
-10.76%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Upcoming events
FAQs
What’s the current market cap for Celcuity stock?
Celcuity (CELC) has a market cap of $511M as of May 16, 2024.
What is the P/E ratio for Celcuity stock?
The price to earnings (P/E) ratio for Celcuity (CELC) stock is 0 as of May 16, 2024.
Does Celcuity stock pay dividends?
No, Celcuity (CELC) stock does not pay dividends to its shareholders as of May 16, 2024.
When is the next Celcuity dividend payment date?
Celcuity (CELC) stock does not pay dividends to its shareholders.
What is the beta indicator for Celcuity?
Celcuity (CELC) has a beta rating of 0.86. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
What is the Celcuity stock price target?
The target price for Celcuity (CELC) stock is $28.6, which is 65.99% above the current price of $17.23. This is an average based on projections from 5 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.
Buy or sell Celcuity stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.